investorscraft@gmail.com

Intrinsic Value of Anika Therapeutics, Inc. (ANIK)

Previous Close$15.11
Intrinsic Value
Upside potential
Previous Close
$15.11

VALUATION INPUT DATA

Revenue, mln $Initial revenue growth rate, %Variable cost ratio, %Fixed operating exp., mln $Prod. assets / Revenue, %Working capital / Revenue, %Interest rate on debt, %Initial discount rate, %Shares outstanding, mlnAdjusted equity ratioAdjusted assets / RevenueCash & ST InvestmentsTotal debt

This valuation is based on fiscal year data as of 2024 and quarterly data as of 2024-12-31.

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %-28.1-26.4-24.9-23.4-22.0-20.6-19.3-18.1-17.0-15.9-14.8-13.8-12.9-12.0-11.1-10.3-9.6-8.8-8.1-7.5-6.9-6.3-5.7-5.2-4.7
Revenue, $86634837282318151210987655444333332
Variable operating expenses, $m7857433326201613119876554433333222
Fixed operating expenses, $m192022242628303336394245495458636874818795103112121131
Total operating expenses, $m977765575248464647485052555963677277849098106114123133
Operating income, $m-10-14-17-20-23-26-28-31-34-38-41-45-49-53-58-63-68-74-80-87-94-103-111-121-131
EBITDA, $m-2-8-13-17-20-24-27-30-33-37-40-44-48-53-57-62-68-74-80-87-94-102-111-121-131
Interest expense (income), $m1322211111111111111111111
Earnings before tax, $m-11-16-19-22-24-27-30-32-35-39-42-46-50-54-58-63-69-75-81-88-95-103-112-122-132
Tax expense, $m0000000000000000000000000
Net income, $m-11-16-19-22-24-27-30-32-35-39-42-46-50-54-58-63-69-75-81-88-95-103-112-122-132

BALANCE SHEET

Cash and short-term investments, $m0000000000000000000000000
Total assets, $m168124937156443629242017151311109887666555
Adjusted assets (=assets-cash), $m168124937156443629242017151311109887666555
Average production assets, $m564131241815121087654433322222222
Working capital, $m4332241814119765443332222221111
Total debt, $m68544538343028262423222221212020201919191919191919
Total liabilities, $m50372821171311976544333222222211
Total equity, $m11887655039312520171412109876655444433
Debt-to-equity ratio0.2040.7800.8330.9020.9891.0931.2171.3611.5251.7091.9112.1312.3682.6182.8813.1533.4323.7153.9994.2824.5604.8325.0945.3445.581
Adjusted equity ratio0.7000.7000.7000.7000.7000.7000.7000.7000.7000.7000.7000.7000.7000.7000.7000.7000.7000.7000.7000.7000.7000.7000.7000.7000.700

CASH FLOW

Net income, $m-11-16-19-22-24-27-30-32-35-39-42-46-50-54-58-63-69-75-81-88-95-103-112-122-132
Depreciation, amort., depletion, $m8643222111111000000000000
Funds from operations, $m-3-11-15-19-22-25-28-31-34-38-41-45-49-53-58-63-68-74-81-88-95-103-112-121-132
Change in working capital, $m-17-11-8-6-4-3-2-2-1-1-1-10000000000000
Cash from operations, $m141-7-13-18-22-26-30-33-37-40-44-49-53-58-63-68-74-81-87-95-103-112-121-132
Maintenance CAPEX, $m-8-6-4-3-2-2-2-1-1-1-1-1-1000000000000
New CAPEX, $m0000000000000000000000000
Total CAPEX, $m-8-6-4-3-2-2-2-1-1-1-1-1-1000000000000
Free cash flow, $m6-5-11-16-20-24-27-31-34-38-41-45-49-53-58-63-69-74-81-88-95-103-112-122-132
Issuance/(repurchase) of shares, $m00041218232731354044485357636874808795103112121132
Retained Cash Flow, $m153122151186533221111110000000
Pot'l extraordinary dividend, $m21
Cash available for distribution, $m392060000000000000000000000
Discount rate, %4.905.155.405.675.966.256.576.897.247.607.988.388.809.249.7010.1910.7011.2311.7912.3813.0013.6514.3315.0515.80
PV of cash for distribution, $m371850000000000000000000000
Current shareholders' claim on cash, %1001001009683634224125210000000000000